These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3445757)

  • 1. [Synthesis of N-(2-mercaptobenzoyl)-N-(alkyl/aryl)-glycines and corresponding disulfides].
    Chen PL; Yang ZX; Peng SX
    Yao Xue Xue Bao; 1987 Sep; 22(9):662-70. PubMed ID: 3445757
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synthesis of N-(4-substituted amino-4-oxobutyryl)-N-substituted glycines].
    Wu Y; Cai CY; Gong KS
    Yao Xue Xue Bao; 1992; 27(9):717-20. PubMed ID: 1293947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthesis of N-(2-mercaptopyridyl-3-formyl)-N-alkyl glycine and the corresponding disulfides].
    Luo YL; Yang ZX; Peng SX
    Yao Xue Xue Bao; 1990; 25(5):374-8. PubMed ID: 2284959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthesis of N-(4-carbethoxy-4-substituted butyryl)-N-substituted glycines].
    Chen YM; Cai CY; Gong KS
    Yao Xue Xue Bao; 1989; 24(12):887-94. PubMed ID: 2486235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors. New orally active antihypertensive (mercaptoalkanoyl)- and [(acylthio)alkanoyl]glycine derivatives.
    Suh JT; Skiles JW; Williams BE; Youssefyeh RD; Jones H; Loev B; Neiss ES; Schwab A; Mann WS; Khandwala A
    J Med Chem; 1985 Jan; 28(1):57-66. PubMed ID: 2981324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological activity of angiotensin converting enzyme inhibitors: N-(mercaptoacyl)-4-substituted-(S)-prolines.
    Smith EM; Swiss GF; Neustadt BR; Gold EH; Sommer JA; Brown AD; Chiu PJ; Moran R; Sybertz EJ; Baum T
    J Med Chem; 1988 Apr; 31(4):875-85. PubMed ID: 2832605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological profile of novel N-substituted N-[5H-[1]benzopyrano[4,3-d]pyrimidin-2-YL]-N-methylglycinamides.
    Bruno O; Schenone S; Ranise A; Bondavalli F; D'Amico M; Filippelli W; Berrino L; Rossi F
    Farmaco; 1996 Feb; 51(2):137-40. PubMed ID: 8857210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthesis of N-(4-carbomethoxy-4-phthalimidobutanoyl)-N-substituted glycines, proline and pyroglutamic acid].
    Lin WQ; Cai CY; Gong KS; Wu Y; Long Z; Luo XX; Yang L; Li JF; Yao XJ
    Yao Xue Xue Bao; 1994; 29(5):346-54. PubMed ID: 7976352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New sulfhydryl compounds with potent antihypertensive activities.
    Mita I; Iwao J; Oya M; Chiba T; Iso T
    Chem Pharm Bull (Tokyo); 1978 Apr; 26(4):1333-5. PubMed ID: 207454
    [No Abstract]   [Full Text] [Related]  

  • 10. [Synthesis of angiotensin converting enzyme inhibitor, captopril ester derivatives].
    Wu M; Xie MH; Zhao DY; Chen GY; Wang YC; Kong H
    Yao Xue Xue Bao; 1988; 23(12):890-4. PubMed ID: 3076736
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and in vitro activities of new non-peptidic APA inhibitors.
    Inguimbert N; Coric P; Dhotel H; Bonnard E; Llorens-Cortes C; Mota N; Fournié-Zaluski MC; Roques BP
    J Pept Res; 2005 Feb; 65(2):175-88. PubMed ID: 15705162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action.
    Fournie-Zaluski MC; Coric P; Thery V; Gonzalez W; Meudal H; Turcaud S; Michel JB; Roques BP
    J Med Chem; 1996 Jun; 39(13):2594-608. PubMed ID: 8691458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and enzymatic evaluation of novel partially fluorinated thiol dual ACE/NEP inhibitors.
    Olimpieri F; Tambaro S; Fustero S; Lazzari P; Sanchez-Roselló M; Pani L; Volonterio A; Zanda M
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4715-9. PubMed ID: 19596577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors. 9. Novel [[N-(1-carboxy-3-phenylpropyl)amino]acyl]glycine derivatives with diuretic activity.
    Barton JN; Piwinski JJ; Skiles JW; Regan JR; Menard PR; Desai R; Golec FS; Reilly LW; Goetzen T; Ueng SN
    J Med Chem; 1990 Jun; 33(6):1600-6. PubMed ID: 2342054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
    Fink CA; Carlson JE; McTaggart PA; Qiao Y; Webb R; Chatelain R; Jeng AY; Trapani AJ
    J Med Chem; 1996 Aug; 39(16):3158-68. PubMed ID: 8759637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive activity of chitin derivatives.
    Je JY; Park PJ; Kim B; Kim SK
    Biopolymers; 2006 Oct; 83(3):250-4. PubMed ID: 16763977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antihypertensive activity evaluation of indole derivatives N-acetamido substituted.
    Grasso S; Molica C; Monforte AM; Monforte P; Zappalà M; Monforte MT; Trovato A
    Farmaco; 1995 Feb; 50(2):113-7. PubMed ID: 7766275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of aryl glycines by the alpha arylation of Weinreb amides.
    Hirner S; Panknin O; Edefuhr M; Somfai P
    Angew Chem Int Ed Engl; 2008; 47(10):1907-9. PubMed ID: 18224640
    [No Abstract]   [Full Text] [Related]  

  • 19. Thiol compounds. I. Synthesis and antihypertensive activity of mercaptoacylamino acids.
    Oya M; Matsumoto J; Takashina H; Iwao J; Funae Y
    Chem Pharm Bull (Tokyo); 1981 Jan; 29(1):63-70. PubMed ID: 7261198
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
    Takata Y; Di Nicolantonio R; Hutchinson JS
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.